Insider Transactions in Q1 2024 at Rigel Pharmaceuticals Inc (RIGL)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 05
2024
|
Raul R Rodriguez CEO, President |
SELL
Open market or private sale
|
Direct |
30,545
-1.48%
|
$30,545
$1.14 P/Share
|
|
Feb 05
2024
|
Dean L Schorno EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,027
-1.71%
|
$7,027
$1.14 P/Share
|
|
Feb 05
2024
|
David A Santos EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
8,918
-2.49%
|
$8,918
$1.14 P/Share
|
|
Feb 02
2024
|
Raul R Rodriguez CEO, President |
SELL
Open market or private sale
|
Direct |
22,349
-1.07%
|
$22,349
$1.13 P/Share
|
|
Feb 02
2024
|
Dean L Schorno EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,601
-1.35%
|
$5,601
$1.13 P/Share
|
|
Feb 02
2024
|
David A Santos EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,601
-1.54%
|
$5,601
$1.13 P/Share
|
|
Jan 23
2024
|
Dean L Schorno EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
209,000
+33.47%
|
-
|
|
Jan 23
2024
|
David A Santos EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
209,000
+36.5%
|
-
|
|
Jan 23
2024
|
Raul R Rodriguez CEO, President |
BUY
Grant, award, or other acquisition
|
Direct |
400,000
+16.07%
|
-
|
|
Jan 23
2024
|
Raymond J. Furey EVP, GC, CCO & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
209,000
+49.41%
|
-
|